← Eichor
Condition: Stage Iiib Lung Cancer Ajcc V8 Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Stage Iiib Lung Cancer Ajcc V8

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Phase 3 · 604 location(s) · National Cancer Institute (NCI) · NCT04181060Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT04789681Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · 1151 location(s) · National Cancer Institute (NCI) · NCT04267848Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lu
Phase 2 · 21 location(s) · Fundación GECP · NCT07153445Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatmen
Phase 2 · 13 location(s) · City of Hope Medical Center · NCT07288034Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Phase 2 · 1 location(s) · Roswell Park Cancer Institute · NCT04067830Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT05010109Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer
Phase 1 · 2 location(s) · Ohio State University Comprehensive Cancer Center · NCT05136846Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT04892953Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The
Phase 3 · 322 location(s) · National Cancer Institute (NCI) · NCT06096844Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · 382 location(s) · Alliance for Clinical Trials in Oncology · NCT06632327Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · 266 location(s) · National Cancer Institute (NCI) · NCT06498635Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT05269381Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
Phase 2 · 1 location(s) · Mayo Clinic · NCT06918132Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cel
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT03948100Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT03819296
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.